B Lynne Parshall sold $359K of Ionis Pharmaceuticals (IONS)

Executed Oct 15 2025, disclosed Oct 16 2025, 1 day later.

Value, as filed

$359K

5,000 sh × $71.74

Executed

Oct 15 2025

the trade date, as filed

Disclosed

Oct 16 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

BP B Lynne Parshall Director profile →

B Lynne Parshall (Director) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Ionis Pharmaceuticals, Inc. (IONS). The largest single filing was $414K of IONS (5,000 sh × $82.72, as filed), executed Feb 11.

The name

IONS Ionis Pharmaceuticals, Inc. IONS · Healthcare · 119 filings in 24 months ticker →

Healthcare · Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by B Lynne Parshall in IONS

IONSSALE Ionis Pharmaceuticals, Inc. $340K
4,466 sh × $76.19
Exec Apr 15
Filed Apr 17 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $414K
5,000 sh × $82.72
Exec Feb 11
Filed Feb 13 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $1.0M
20,000 sh across 2 lots
Exec Sep 2 2025
Filed Sep 4 2025 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $193K
4,600 sh × $41.87
Exec Aug 6 2025
Filed Aug 8 2025 · 5:30 PM ET